![Dorman Followwill](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 357 $ in data 31/08/2026
Dorman Followwill is currently an Independent Director at Semnur Pharmaceuticals, Inc. since 2025, an Independent Director at Scilex Holding Co. since 2022, and a Senior Partner-Transformational Health at Frost & Sullivan, Inc. since 2016.
Former positions include Independent Director at Scilex, Inc. in 2022 and Independent Director at Sorrento Therapeutics, Inc. from 2017 to 2020.
Education includes an undergraduate degree from Stanford University conferred in 1985.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 28/04/2026 | 65 ( 0% ) | 357 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| SCILEX HOLDING COMPANY | Direttore/Membro del Consiglio | 10/11/2022 |
Frost & Sullivan, Inc.
 Frost & Sullivan, Inc. Investment ManagersFinance Provides investment research | Corporate Officer/Principal | 01/01/2016 |
| Società | Posizione | Fine |
|---|---|---|
Scilex, Inc.
 Scilex, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pain management pharmaceutical products | Direttore/Membro del Consiglio | 01/11/2022 |
| SORRENTO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Frost & Sullivan, Inc.
Frost & Sullivan, Inc. Investment ManagersFinance Provides investment research | Finance |
Sorrento Therapeutics, Inc.
 Sorrento Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical and commercial stage biopharmaceutical company that develops treatments for cancer, infectious disease and pain | Health Technology |
Scilex, Inc.
Scilex, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pain management pharmaceutical products | Health Technology |
Scilex Holding Co.
 Scilex Holding Co. Pharmaceuticals: OtherHealth Technology Manufactures and wholesales non-opioid pain management products | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
